Global Intraoperative Radiation Therapy Market, By Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, and Others), Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, and Software and Services), Type (Portable and Benchtop), Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, and Upper Gastro-Intestinal Tumors Other Cancer), End User (Hospital, Ambulatory Surgical Centers, Specialty Center, and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
Intraoperative radiation therapy Market Analysis and Size
IORT has shown its efficacy in various tumors and cancers, such as recurrent gynecological cancers, recurrent colorectal cancers, and soft-tissue tumors. It is observed that IORT treatment was used at the primary site in 42.5% of the cases and regional nodes in 57.7%. Lately, it has evolved as a popular treatment option for selected, early-stage breast cancers due to the ability to complete the entire course of radiotherapy during surgery. Also, an increase in the wide adoption of minimally invasive surgeries, mostly dependent on the imaging chain, is anticipated to promote market growth.
Data Bridge Market Research analyses that the intraoperative radiation therapy market, which was USD 283.94 million in 2022, would rise to USD 498.91 million by 2030 and is expected to undergo a CAGR of 7.30% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Intraoperative radiation therapy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, and Others), Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, and Software and Services), Type (Portable and Benchtop), Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, and Upper Gastro-Intestinal Tumors Other Cancer), End User (Hospital, Ambulatory Surgical Centers, Specialty Center, and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
IntraOp Medical, Inc (U.S.), Varian Medical Systems, Inc (U.S.), Eckert & Ziegler (Germany), Sensus Healthcare (U.S.)., Elekta (Sweden)., REMEDI Co., Ltd (South Korea), Brainlab AG (Germany), Sensus Healthcare (U.S.), Elekta (Sweden)
|
|
Market Opportunities
|
|
Market Definition
Intraoperative radiotherapy (IORT) is a technique that includes delivering a high dose of ionizing radiation to the tumor during surgery. It also includes the direct visualization of the tumor bed. It spaces out normal tissues from the tumor bed, maximizing the tumor dose and reducing it to normal tissues. Therefore, IORT can provide a higher total effective dose to the tumor bed and enable dose escalation without considerably increasing normal tissue complications.
Global Intraoperative radiation therapy Market Dynamics
Drivers
- Increasing Prevalence of Cancer
A rise in cancer incidence rate globally is expected to boost the market during the forecast period, as radiation therapy is used in approximately 50% of all cancer treatments. According to GLOBOCAN 2021, there were around 19.3 million new cancer cases worldwide in 2020, which is anticipated to rise to 30.2 million by 2040. As nuclear medicines are widely used in cancer treatment, such as radiotherapy, there is a growing demand for nuclear medicine radioisotopes, thus boosting the market. The growing number of cancer cases would generate the need for nuclear medicine radioisotopes for treatment, enhancing the market's growth. Thus, this factor boosts market growth.
Opportunities
- Increasing Product Launches by Market Players
Several intraoperative imaging technologies, such as c-arm, iUltrasound, and iMRI, have greatly extended surgical possibilities. The ability to see bones and soft tissue with extreme precision has changed the surgical care of several disorders, including orthopedics, cardiology, neurology, vascular, and neurology. The persistent advances in intraoperative imaging technologies, such as 3D and real-time imaging, are anticipated to expand the market. For instance, the FDA granted GE Healthcare clearance for OEC 3D, a surgical imaging system capable of 3D and 2D imaging, in 2021. By offering precise volumetric images, OEC 3D sets a goal to set a benchmark for intraoperative 3D imaging for spine and orthopedic surgeries. Thus, this factor boosts market growth.
- Growing Demand for iMRI
The increasing demand for iMRI is anticipated to grow significantly during the forecast period. The iMRI system's high-quality images enable higher precision in difficult surgeries and offer real-time images, greatly decreasing the chances of inaccuracy and the absence of ionizing radiation. These have assisted the development of iMRI as an important tool for surgeries. Thus, this factor boosts the market's growing rapidly.
Restraints/Challenges
- Risk Associated With High Dose Radiation Exposure
A huge risk is associated with high-dose radiation exposure that impedes the market growth rate. Exposure to very high radiation levels can lead to acute health effects such as skin burns and acute radiation syndrome. Furthermore, it can also result in prolonged health effects such as cardiovascular disease and cancer. Therefore, these factors hamper the market growth.
This intraoperative radiation therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intraoperative radiation therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Varian Medical Systems, Inc. signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to fight the global cancer burden. This will assist the company in surging its access to care across regional and underserviced areas in Australia and Asia.
Global Intraoperative Radiation Therapy Market Scope
The intraoperative radiation therapy market is segmented on the basis of method, product, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Method
- Electron
- Intraoperative Brachytherapy
- High Dose-Rate
- X-Ray
- Others
Product
- Intraoperative Radiation Therapy Devices
- Intraoperative Radiation Therapy Accessories
- Software and Services
Type
- Portable
- Benchtop
Application
- Breast Cancer
- Brain Tumor
- Head and Neck Cancer
- Soft Tissue Sarcoma
- Pediatric Tumors
- Gynecological Cancer
- Genitourinary Cancers
- Upper Gastro-Intestinal Tumor
- Other Cancer
End User
- Hospital
- Ambulatory Surgical Centers
- Specialty Center
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Intraoperative Radiation Therapy Market Regional Analysis/Insights
The intraoperative radiation therapy market is analyzed and market size insights and trends are provided by method, product, type, application, end user, and distribution channel as referenced above.
The countries covered in the intraoperative radiation therapy market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the intraoperative radiation therapy market due to the due to a huge number of market players in the region, their persistent efforts in launching new products, and R&D activities to support easy operations and assure the wide availability of authentic medical-grade imaging systems.
North America is expected to witness significant growth due to increasing acceptance and huge usage of IORT in treating cancer patients in the region. Moreover, the growing prevalence of chronic disorders is anticipated to increase market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The intraoperative radiation therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intraoperative radiation therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intraoperative radiation therapy market. The data is available for historic period 2011-2021.
Competitive Landscape and Intraoperative Radiation Therapy Market Share Analysis
The intraoperative radiation therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intraoperative radiation therapy market.
Some of the major players operating in the intraoperative radiation therapy market are:
- IntraOp Medical, Inc (U.S.)
- Varian Medical Systems, Inc (U.S.)
- Eckert & Ziegler (Germany)
- Sensus Healthcare (U.S.)
- Elekta (Sweden)
- REMEDI Co.,Ltd(South Korea)
- Brainlab AG (Germany)
- Sensus Healthcare (U.S.)
- Elekta (Sweden)
SKU-